Title:
ANTIBODIES TARGETING TIGIT AND USES THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/041639
Kind Code:
A1
Abstract:
The present disclosure relates to an antibody, such as a monoclonal antibody (mAb), or an antigen-binding fragment thereof, that specifically recognizes TIGIT, and methods of making the same and using the same.
More Like This:
WO/2020/210451 | DEGRADERS OF FIBROBLAST GROWTH FACTOR RECEPTOR 2 (FGFR2) |
WO/1996/011269 | TIE-2 LIGANDS, METHODS OF MAKING AND USES THEREOF |
JP2001510483 | [Title of Invention] Recovery of Protein |
Inventors:
YANG SHUAI (CN)
WANG SUJUAN (CN)
LIU JIAN (CN)
ZHANG YAFENG (CN)
SUN QING (CN)
SUN WEI (CN)
WU SHU (CN)
TANG AN (CN)
WANG SUJUAN (CN)
LIU JIAN (CN)
ZHANG YAFENG (CN)
SUN QING (CN)
SUN WEI (CN)
WU SHU (CN)
TANG AN (CN)
Application Number:
PCT/CN2023/114953
Publication Date:
February 29, 2024
Filing Date:
August 25, 2023
Export Citation:
Assignee:
NANJING LEGEND BIOTECH CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P35/00; C12N15/13
Foreign References:
CN108883164A | 2018-11-23 | |||
CN110352200A | 2019-10-18 | |||
CN111601826A | 2020-08-28 | |||
CN108290936A | 2018-07-17 | |||
CN109384846A | 2019-02-26 | |||
CN108290946A | 2018-07-17 | |||
CN111526888A | 2020-08-11 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: